biotect-valuation

The premium Open Source alternative to Evaluate Pharma

🎯 Best for:Financial analysts requiring transparent biotech valuation methodologies

What is biotect-valuation?

Replaces manual biotech financial modeling with an AI-driven 4-factor framework. Automates risk-adjusted NPV calculations using clinical trial success probabilities and market data.

Tech Stack
PythonFinance & Accounting

Why biotect-valuation?

  • Automated rNPV calculation
  • AI-driven risk assessment
  • Transparent valuation logic

Limitations

  • Requires financial domain knowledge
  • API costs for LLM usage
  • Limited historical data
12/14/2025
Last Update
0
Forks
0
Issues
Unknown
License
Financial Leak Detected

Stop the "SaaS Tax"

Your team could be burning cash. Switching to biotect-valuation instantly boosts your runway.

Competitor Cost
-$1,440
/ year (est. based on Evaluate Pharma)
Self-Hosted
$0
/ year
Team Size10 Users
150+
SAVE 100%

Community Discussion

Comments